Published in J Int AIDS Soc on February 25, 2014
Estimating the Cost-Effectiveness of HIV Prevention Programmes in Vietnam, 2006-2010: A Modelling Study. PLoS One (2015) 0.80
The funding landscape for HIV in Asia and the Pacific. J Int AIDS Soc (2015) 0.78
Armed Conflict, Substance Use and HIV: A Global Analysis. AIDS Behav (2016) 0.75
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med (2010) 50.17
Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89
Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ (1996) 10.84
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet (2010) 8.02
Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet (2010) 5.02
Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ (2005) 3.83
Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan (2001) 3.30
Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countries. Sex Transm Infect (2008) 3.19
The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science (2006) 2.76
The quality of reporting in published cost-utility analyses, 1976-1997. Ann Intern Med (2000) 2.71
Costs and efficiency of integrating HIV/AIDS services with other health services: a systematic review of evidence and experience. Sex Transm Infect (2011) 1.91
Cost-effectiveness analysis: can we reduce variability in costing methods? Int J Technol Assess Health Care (2003) 1.90
Scaling up prevention programmes to reduce the sexual transmission of HIV in China. Int J Epidemiol (2010) 1.71
From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand. Southeast Asian J Trop Med Public Health (1998) 1.64
Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine. PLoS Med (2011) 1.62
Benefits and costs of expanding access to family planning programs to women living with HIV. AIDS (2009) 1.60
HIV prevention cost-effectiveness: a systematic review. BMC Public Health (2009) 1.58
Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India. BMC Public Health (2007) 1.57
Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy. AIDS (2007) 1.34
The cost-effectiveness of policies for the safe and appropriate use of injection in healthcare settings. Bull World Health Organ (2003) 1.22
The economics of effective AIDS treatment in Thailand. AIDS (2007) 1.21
The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine. Sex Transm Dis (2006) 1.16
Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia. PLoS One (2010) 1.15
The cost-effectiveness and budget impact of Vietnam's methadone maintenance treatment programme in HIV prevention and treatment among injection drug users. Glob Public Health (2012) 1.12
Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options. Sex Transm Dis (2006) 1.10
Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings. AIDS (2011) 1.08
Needle and syringe programs in Yunnan, China yield health and financial return. BMC Public Health (2011) 1.05
Contributions of international cooperation projects to the HIV/AIDS response in China. Int J Epidemiol (2010) 1.02
The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia. Int J Tuberc Lung Dis (2009) 1.02
Cost-effectiveness analysis of antiretroviral drug treatment and HIV-1 vaccination in Thailand. Jpn J Infect Dis (2006) 1.01
Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand. BMC Public Health (2010) 0.99
Cost effectiveness of targeted HIV prevention interventions for female sex workers in India. Sex Transm Infect (2011) 0.98
The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus. Addiction (2004) 0.98
Cost-effectiveness of HIV prevention interventions in Andhra Pradesh state of India. BMC Health Serv Res (2010) 0.97
The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh. Addiction (2009) 0.97
The potential impact of an HIV vaccine with limited protection on HIV incidence in Thailand: a modeling study. Vaccine (2011) 0.96
The epidemiological impact and cost-effectiveness of HIV testing, antiretroviral treatment and harm reduction programs. AIDS (2012) 0.95
The potential demand for an AIDS vaccine in Thailand. Health Policy (2001) 0.93
Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India. PLoS One (2013) 0.91
Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India. Health Policy (2005) 0.87
Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand. BMC Public Health (2011) 0.87
The cost-effectiveness analysis of initiating HIV/AIDS treatment with efavirenz-based regimens compared with nevirapine-based regimens in Thailand. J Med Assoc Thai (2008) 0.86
The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis. PLoS One (2012) 0.86
Cost-effectiveness of highly active antiretroviral therapy for HIV infection in Taiwan. J Formos Med Assoc (2007) 0.85
Economic evaluation of methadone maintenance treatment in HIV/AIDS control among injecting drug users in Dehong, China. AIDS Care (2011) 0.85
Cost-effectiveness of methadone maintenance therapy as HIV prevention in an Indonesian high-prevalence setting: a mathematical modeling study. Int J Drug Policy (2012) 0.85
Universal antenatal human immunodeficiency virus (HIV) testing programme is cost-effective despite a low HIV prevalence in Hong Kong. Hong Kong Med J (2007) 0.84
Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India. PLoS One (2010) 0.84
Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands. Transfusion (2009) 0.83
The cost-effectiveness of HIV voluntary counseling and testing in China. Asia Pac J Public Health (2011) 0.83
Cost-effectiveness analysis of partner notification program for human immunodeficiency virus infection in Japan. J Epidemiol (1998) 0.83
The cost-effectiveness of treating male trichomoniasis to avert HIV transmission in men seeking sexually transmitted disease care in Malawi. J Acquir Immune Defic Syndr (2006) 0.82
Net financial benefits of averting HIV infections among people who inject drugs in Urumqi, Xinjiang, Peoples Republic of China (2005-2010). BMC Public Health (2012) 0.82
Cost and cost-effectiveness of antiretroviral therapy for HIV infection in Singapore. Int J STD AIDS (2006) 0.82
Cost-effectiveness of voluntary HIV screening in Russia. Int J STD AIDS (2009) 0.81
Modeling the cost-effectiveness of HIV treatment: how to buy the most 'health' when resources are limited. Curr Opin HIV AIDS (2013) 0.79
Economic impact of HIV and antiretroviral therapy on education supply in high prevalence regions. PLoS One (2012) 0.78
Economic evaluation of treatment administration strategies of ganciclovir for cytomegalovirus retinitis in HIV/AIDS patients in Thailand: a simulation study. Pharmacoeconomics (2007) 0.77
Estimated economic losses of hospitalized AIDS patients at Siriraj Hospital from January 2003 to December 2003: time for aggressive voluntary counseling and HIV testing. J Med Assoc Thai (2005) 0.77